ALESSE Drug Patent Profile
✉ Email this page to a colleague
When do Alesse patents expire, and what generic alternatives are available?
Alesse is a drug marketed by Cadence Health and is included in one NDA.
The generic ingredient in ALESSE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALESSE?
- What are the global sales for ALESSE?
- What is Average Wholesale Price for ALESSE?
Summary for ALESSE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Clinical Trials: | 3 |
| DailyMed Link: | ALESSE at DailyMed |
Recent Clinical Trials for ALESSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Novartis | Phase 2 |
| Université de Montréal | Phase 2 |
| National Institutes of Health (NIH) | Phase 4 |
US Patents and Regulatory Information for ALESSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cadence Health | ALESSE | ethinyl estradiol; levonorgestrel | TABLET;ORAL-21 | 020683-001 | Mar 27, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cadence Health | ALESSE | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 020683-002 | Mar 27, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
